Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
14
TLT.V Quote, Financials, Valuation and Earnings
Last price:
$0.15
Seasonality move
:
-11.32%
Day range:
$0.15 - $0.16
52-week range:
$0.15 - $0.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
38.51x
P/B ratio:
36.47x
Volume:
188.8K
Avg. volume:
203.5K
1-year change:
-38.78%
Market cap:
$39.8M
Revenue:
$1M
EPS (TTM):
-$0.02
Analysts' Opinion
-
Consensus RatingTheralase Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $0.70, Theralase Technologies, Inc. has an estimated upside of 351.61% from its current price of $0.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.70 representing 100% downside risk from its current price of $0.15.
Fair Value
-
According to the consensus of 1 analyst, Theralase Technologies, Inc. has 351.61% upside to fair value with a price target of $0.70 per share.
TLT.V vs. S&P 500
-
Over the past 5 trading days, Theralase Technologies, Inc. has underperformed the S&P 500 by -2.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Theralase Technologies, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Theralase Technologies, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Theralase Technologies, Inc. reported revenues of $279.6K.
Earnings Growth
-
Theralase Technologies, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Theralase Technologies, Inc. reported earnings per share of -$0.00.
Enterprise value:
40.1M
EV / Invested capital:
28.38x
Price / LTM sales:
38.51x
EV / EBIT:
--
EV / Revenue:
40.05x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-15.34x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$314.9K
Return On Assets:
-140.89%
Net Income Margin (TTM):
-434.93%
Return On Equity:
-283.94%
Return On Invested Capital:
-238.89%
Operating Margin:
-364.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1M | $986.6K | $1M | $346.6K | $279.6K | |
| Gross Profit | $284.9K | $260.7K | $314.9K | $138.7K | $98.6K | |
| Operating Income | -$4.5M | -$4.4M | -$4.4M | -$949.5K | -$1M | |
| EBITDA | -$4.2M | -$4.1M | -$4.1M | -$881.2K | -$953.8K | |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.00 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.1M | $3.4M | $1.3M | $1.7M | $1.5M | |
| Total Assets | $7.1M | $4.9M | $3M | $3.2M | $3M | |
| Current Liabilities | $822.1K | $853.1K | $1.1M | $863.5K | $1.8M | |
| Total Liabilities | $822.1K | $1.3M | $1.4M | $1.1M | $1.9M | |
| Total Equity | $6.3M | $3.7M | $1.6M | $2.1M | $1.1M | |
| Total Debt | $50.3K | $487.4K | $409.1K | $317.7K | $219.8K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.9M | -$4.1M | -$2.5M | -$1.4M | -$687.1K | |
| Cash From Investing | -$89.2K | -$24.5K | -$97.9K | -$8.6K | -$15.2K | |
| Cash From Financing | $1.8M | $4.2M | $2.4M | $1.3M | $736.9K | |
| Free Cash Flow | -$4M | -$4.1M | -$2.6M | -$1.4M | -$702.3K | |
TLT.V
Sector
Market Cap
$39.8M
$28.4M
Price % of 52-Week High
46.27%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-4.91%
-1.49%
1-Year Price Total Return
-38%
-16.67%
Beta (5-Year)
0.540
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.16
200-day SMA
Sell
Level
$0.19
Bollinger Bands (100)
Sell
Level
0.17 - 0.21
Chaikin Money Flow
Sell
Level
-187.3K
20-day SMA
Sell
Level
$0.16
Relative Strength Index (RSI14)
Sell
Level
36.09
ADX Line
Sell
Level
8.35
Williams %R
Neutral
Level
-50
50-day SMA
Sell
Level
$0.18
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-20.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4792)
Sell
CA Score
(Annual)
Level (-5.7676)
Buy
Beneish M-Score
(Annual)
Level (-3.7705)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (11.2663)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, TLT.V has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TLT.V average analyst price target in the past 3 months is $0.70.
-
Where Will Theralase Technologies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Theralase Technologies, Inc. share price will rise to $0.70 per share over the next 12 months.
-
What Do Analysts Say About Theralase Technologies, Inc.?
Analysts are divided on their view about Theralase Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Theralase Technologies, Inc. is a Sell and believe this share price will drop from its current level to $0.70.
-
What Is Theralase Technologies, Inc.'s Price Target?
The price target for Theralase Technologies, Inc. over the next 1-year time period is forecast to be $0.70 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TLT.V A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Theralase Technologies, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of TLT.V?
You can purchase shares of Theralase Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Theralase Technologies, Inc. shares.
-
What Is The Theralase Technologies, Inc. Share Price Today?
Theralase Technologies, Inc. was last trading at $0.15 per share. This represents the most recent stock quote for Theralase Technologies, Inc.. Yesterday, Theralase Technologies, Inc. closed at $0.15 per share.
-
How To Buy Theralase Technologies, Inc. Stock Online?
In order to purchase Theralase Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get TLT.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TLT.V
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
36.47x
1.81x
Price / LTM sales
38.51x
1.58x
Growth Metrics
TLT.V
Sector
Revenue growth
-19.32%
4.62%
Earnings growth
--
10.7%
Revenue (5-year growth)
1.4%
6.5%
Earnings forecast
--
-$0.21
Profitability
TLT.V
Sector
Profitability FY 2024
$305.2K
$3.6M
Return on invested capital
-238.89%
-31.84%
Return on assets
-140.89%
-27.96%
Return on equity
-283.94%
-37.63%
Earnings Date
Last Earnings Date
Dec
24
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
TLT.V
Sector
Total cash
$81K
$26.4M
Short term investments
--
$25.7M
Total assets
$3.2M
$76.9M
Long term debt
$219.8K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
